| Polymer degradation and in vitro release of a model protein from poly (D, L-lactide-co-glycolide) nano-and microparticles J Panyam, MM Dali, SK Sahoo, W Ma, SS Chakravarthi, GL Amidon, ... Journal of controlled release 92 (1-2), 173-187, 2003 | 681 | 2003 |
| Efficacy of transferrin‐conjugated paclitaxel‐loaded nanoparticles in a murine model of prostate cancer SK Sahoo, W Ma, V Labhasetwar International journal of cancer 112 (2), 335-340, 2004 | 424 | 2004 |
| Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia T Sanda, LN Lawton, MI Barrasa, ZP Fan, H Kohlhammer, A Gutierrez, ... Cancer cell 22 (2), 209-221, 2012 | 344 | 2012 |
| A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition DJ Goff, A Sadarangani, HJ Chun, CL Barrett, M Krajewska, H Leu, ... Cell stem cell 12 (3), 316-328, 2013 | 189 | 2013 |
| Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell–based therapeutics JG Zhang, J Eguchi, CA Kruse, GG Gomez, H Fakhrai, S Schroter, W Ma, ... Clinical Cancer Research 13 (2), 566-575, 2007 | 185 | 2007 |
| TYK2–STAT1–BCL2 pathway dependence in T-cell acute lymphoblastic leukemia T Sanda, JW Tyner, A Gutierrez, VN Ngo, J Glover, BH Chang, A Yost, ... Cancer discovery 3 (5), 564-577, 2013 | 141 | 2013 |
| Inactivation of LEF1 in T-cell acute lymphoblastic leukemia A Gutierrez, T Sanda, W Ma, J Zhang, R Grebliunaite, S Dahlberg, ... Blood, The Journal of the American Society of Hematology 115 (14), 2845-2851, 2010 | 139 | 2010 |
| PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses W Ma, M Chen, S Kaushal, M McElroy, Y Zhang, C Ozkan, M Bouvet, ... International journal of nanomedicine, 1475-1487, 2012 | 132 | 2012 |
| Delivery of a peptide via poly (d, l-lactic-co-glycolic) acid nanoparticles enhances its dendritic cell–stimulatory capacity C Clawson, CT Huang, D Futalan, DM Seible, R Saenz, M Larsson, W Ma, ... Nanomedicine: Nanotechnology, Biology and Medicine 6 (5), 651-661, 2010 | 113 | 2010 |
| Dendritic cell activating peptides induce distinct cytokine profiles G Telusma, S Datta, I Mihajlov, W Ma, J Li, H Yang, W Newman, ... International immunology 18 (11), 1563-1573, 2006 | 81 | 2006 |
| Intracellular delivery of molecular cargo using cell-penetrating peptides and the combination strategies H Li, TY Tsui, W Ma International journal of molecular sciences 16 (8), 19518-19536, 2015 | 72 | 2015 |
| Hyper-editing of cell-cycle regulatory and tumor suppressor RNA promotes malignant progenitor propagation Q Jiang, J Isquith, MA Zipeto, RH Diep, J Pham, ND Santos, E Reynoso, ... Cancer cell 35 (1), 81-94. e7, 2019 | 71 | 2019 |
| CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells J Zhou, A Bashey, R Zhong, S Corringham, K Messer, M Pu, W Ma, T Chut, ... Biology of Blood and Marrow Transplantation 17 (5), 682-692, 2011 | 58 | 2011 |
| Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy W Ma, T Smith, V Bogin, Y Zhang, C Ozkan, M Ozkan, M Hayden, ... Journal of translational medicine 9, 1-10, 2011 | 49 | 2011 |
| The prognostic value of adhesion molecule CD44v6 in women with primary breast carcinoma: a clinicopathologic study W Ma, Y Deng, L Zhou Clinical oncology 17 (4), 258-263, 2005 | 47 | 2005 |
| Circulating tumor cell clusters-associated gene plakoglobin and breast cancer survival L Lu, H Zeng, X Gu, W Ma Breast Cancer Research and Treatment 151, 491-500, 2015 | 41 | 2015 |
| NOTCH1 signaling promotes human T-cell acute lymphoblastic leukemia initiating cell regeneration in supportive niches W Ma, A Gutierrez, DJ Goff, I Geron, A Sadarangani, CAM Jamieson, ... PLoS One 7 (6), e39725, 2012 | 39 | 2012 |
| Nanoparticle-mediated p53 gene therapy for tumor inhibition B Sharma, W Ma, IM Adjei, J Panyam, S Dimitrijevic, V Labhasetwar Drug delivery and translational research 1, 43-52, 2011 | 36 | 2011 |
| PCSD1, a new patient-derived model of bone metastatic prostate cancer, is castrate-resistant in the bone-niche E Godebu, M Muldong, A Strasner, CN Wu, SC Park, JR Woo, W Ma, ... Journal of translational medicine 12, 1-12, 2014 | 32 | 2014 |
| A novel approach for cancer immunotherapy: tumor cells with anchored superantigen SEA generate effective antitumor immunity W Ma, H Yu, Q Wang, H Jin, J Solheim, V Labhasetwar Journal of clinical immunology 24, 294-301, 2004 | 30 | 2004 |
Catriona JamiesonProfessor of Medicine and Chief, Division of Regenerative Medicine, UC San DiegoVerified email at ucsd.edu
